Cargando…
Corrigendum to “Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling”
Autores principales: | Cheng, Xiaoli, Liu, Dan, Xing, Ruinan, Song, Haixu, Tian, Xiaoxiang, Yan, Chenghui, Han, Yaling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273436/ https://www.ncbi.nlm.nih.gov/pubmed/35832841 http://dx.doi.org/10.1155/2022/9828942 |
Ejemplares similares
-
Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling
por: Cheng, Xiaoli, et al.
Publicado: (2020) -
The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes
por: Liu, Dan, et al.
Publicado: (2023) -
Corrigendum to “Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis”
por: Gao, Yunan, et al.
Publicado: (2017) -
Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin [Corrigendum]
Publicado: (2021) -
Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”
por: Zhang, Jianwei, et al.
Publicado: (2022)